Why Is INTEGRA LIFESCIENCES (IART) Stock Down Today?
By the Top Tier Newswire AI Desk · reviewed against 11 wire stories
INTEGRA LIFESCIENCES (IART) is down -15.32% in the latest session. Our newswire has captured 11 stories on IART across 7 sources in the last 36 hours, with AI sentiment reading mixed (avg 47/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for IART publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
IART · today's session (5-min) · -14.29% vs prior close · updated 9:31 AM ETAI sentiment, last 36h · averaged over 11 stories · 47/100 neutral
The headlines behind the move
Story flow · 10 stories on the wire, last 36h · hover or tap a dot for the headline
14m agoInvesting.com MarketsBEARISH 32Earnings
Integra LifeSciences stock tumbles after cutting 2026 outlook
Integra LifeSciences stock tumbles after cutting 2026 outlook
37m agoMarketChameleonNEUTRAL 53General
Integra LifeSciences targets $190–$200 million in 2026 operating cash flow despite flood-driven revenue headwinds
October 2, 2026
Integra LifeSciences (IART) issued unaudited preliminary Q3 2026 results and lowered full-year revenue and adjusted EPS guidance after July flooding at its Cincinnati facility disrupted supply. The company estimated a roughly $7 million revenue hit in Q3 and expects a $15–$20 million impact in Q4, while still forecasting approximately $190–$200 million in operating cash flow for 2026.
1h agoBusiness InsiderBEARISH 34Earnings
Integra slips after guidance cut due to flooding event
Integra LifeSciences (IART) stock drops after a flood-hit facility prompts the company to cut its guidance to a level below consensus. Read more here.
1h agoTipRanksBEARISH 38General
Integra Lifesciences Cuts Outlook After Cincinnati Flooding
The latest announcement is out from Integra Lifesciences ( ($IART) ). Integra LifeSciences, a global medical technology company specializing in neurosurgery and tis...
1h agoThe FlyBULLISH 62M&A
StoneX Group signs agreement to acquire Integra Trading
1h agoGlobeNewswireBULLISH 67M&A
StoneX Group Inc. Acquires Integra Trading S.A.S., Establishing a Colombian Coffee Origination and Processing Platform
Acquisition deepens StoneX Supply & Trading's physical coffee business with direct access to one of the world's premier coffee producing countries
1h agoThe FlyBEARISH 38Earnings
Integra LifeSciences cut FY26 adjusted EPS view to $2.30-$2.40 from $2.40-$2.50
Filed: 2026-10-02 AccNo: 0000917520-26-000067 Size: 194 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
2h agoBusiness InsiderBULLISH 56Earnings
Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today provided certain unaudited preliminary third quarter...
Frequently asked questions
Why is IART stock down today?
INTEGRA LIFESCIENCES (IART) is down -15.32% in the latest session. Our newswire has captured 11 stories on IART across 7 sources in the last 36 hours, with AI sentiment reading mixed (avg 47/100). The most recent driver: "Integra LifeSciences stock tumbles after cutting 2026 outlook" (Investing.com Markets).
Is IART a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of IART coverage reads 47/100 over 11 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →